Human ITGB1 adenoviral particles

The ITGB1 gene, also known as integrin beta-1, encodes a key subunit of the integrin family of cell surface receptors. Integrins are heterodimeric proteins composed of α and β subunits that play key roles in cell adhesion, migration, signaling, and extracellular matrix (ECM) interactions. ITGB1 pairs with various α subunits to form functional integrins, such as α5β1 (fibronectin receptor) and αVβ1 (vitronectin receptor), which mediate interactions with ECM components such as fibronectin, laminin, and collagen. These interactions are critical for processes such as embryonic development, tissue repair, immune responses, and cancer progression. ITGB1 dysregulation is associated with a variety of pathologies, including fibrosis, metastatic cancer, and autoimmune diseases, making it an important target for biomedical research.

Human ITGB1 adenoviral particles are recombinant adenoviral vectors designed to deliver the ITGB1 gene to target cells, resulting in efficient transduction and stable gene expression. Adenoviral vectors are widely used in gene therapy and research due to their high infectivity, broad tropism, and ability to transduce both dividing and non-dividing cells. The particles are replication-defective, ensuring safety by preventing uncontrolled viral replication. The delivered ITGB1 gene can be used to overexpress the integrin β-1 subunit, allowing researchers to study its functional role in cell adhesion, mechanotransduction, and disease mechanisms. In addition, these particles can serve as a tool for gene therapy development, especially when integrin-mediated pathways are disrupted.